Oral Paricalcitol

By Deeks Emma D.   Lyseng-Williamson Katherine A.  

Treatments in Endocrinology, Vol. 5, Iss. 5, 2006-01 ,pp. : 319-325

Adis International

Access to resources Recommend Favorite

Treatment with oral paricalcitol in daily clinical practice for patients with chronic kidney disease stage 3-4: a preliminary study

By Hadjiyannakos Dimitrios   Filiopoulos Vassilis   Trompouki Sofia   Sonikian Makroui   Karatzas Ioannis   Panagiotopoulos Konstantinos   Vlassopoulos Dimosthenis  

Clinical Kidney Journal, Vol. 6, Iss. 2, 2013-04 ,pp. : 164-168

Oxford University Press

Access to resources Recommend Favorite

Spotlight on Paricalcitol in Secondary Hyperparathyroidism

By Robinson Dean M.   Scott Lesley J.  

Treatments in Endocrinology, Vol. 4, Iss. 3, 2005-01 ,pp. : 185-186

Adis International

Access to resources Recommend Favorite

Amphotericin B-Induced in vitro Postantifungal Effect on Candida Species of Oral Origin

By  

Medical Principles and Practice, Vol. 21, Iss. 5, 2012-06 ,pp. : 442-446

Karger

Access to resources Recommend Favorite

Blood levels of homocysteine, folate, vitamin B 6 and B 12 in women using oral contraceptives compared to non-users

By Lussana F.   Zighetti M.L.   Bucciarelli P.   Cugno M.   Cattaneo M.  

Thrombosis Research, Vol. 112, Iss. 1, 2003-01 ,pp. : 37-41

Elsevier

Access to resources Recommend Favorite